Summary
Fibrinogen factor I is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Also known as fibrin glue or fibrin sealant, the majority of available formulations contain a mixture of pooled plasmaderived fibrinogen and the enzyme thrombin.
The global Fibrinogen Concentrate market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export import
Key manufacturers manufacturing sites, capacity and production, product specifications etc.
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
CSL Behring
Baxter
Johnson Johnson Ethicon
LFB Group
ProFibrix BV The Medicines Company
Shanghai RAAS
Jiangxi Boya BioPharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
Greencross
Shanghai XinXing Medical
Major applications as follows:
Congenital Fibrinogen Deficiency
Surgical Procedures Trauma Patients, Cardiovascular Surgery Patients, PPH Patients, Plastic Surgery Patients
Regional market size, production data and export import:
AsiaPacific
North America
Europe
South America
Middle East Africa
Original Article: Global Fibrinogen Concentrate Market Data Survey Report 2025 [Report Updated: 04112017] Prices from USD $1500
NEXT ARTICLE